A multicentric clinical trial comparing Otocerol with Cerumol as cerumenolytics.
Fifteen general practitioners conducted a randomized, double-blind comparative trial of two cerumenolytics, namely, Otocerol and Cerumol. A total of 106 patients were entered into the study (fifty-three in each group). Otocerol was shown to be marginally better than Cerumol in all parameters evaluated.
D000293:Adolescent; D000328:Adult; D000368:Aged; D010367:Arachis; D001566:Benzocaine / Q000494:pharmacology*; D002571:Cerumen / Q000187:drug effects*; D002648:Child; D002722:Chlorobenzenes / Q000494:pharmacology*; D002724:Chlorobutanol; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004338:Drug Combinations; D004341:Drug Evaluation; D004424:Ear Canal; D004427:Ear Diseases / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009821:Oils / Q000494:pharmacology*; D010938:Plant Oils
D002722:Chlorobenzenes; D004338:Drug Combinations; D009821:Oils; D010938:Plant Oils; C016297:arachis oil, chlorobutanol, paradichlorobenzene drug combination; D002724:Chlorobutanol; D001566:Benzocaine